CLINICAL_TRIALS
trial_result
· 2019-08-22
Clinical Trial Update: A Study of Cariprazine in Patients With Chronic Stable Schizophrenia [Phase 2]
Summary
Phase 2 study of cariprazine in chronic stable schizophrenia has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forest Laboratories | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2019-08-22